Carcinoid syndrome
12 Oct 2016
Carcinoid syndrome
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry
Highlights of ESMO 2016
Adjuvant sunitinib for renal cell carcinoma
Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer
Custirsen shows no survival benefit in metastatic prostate cancer
Cabozantinib over sunitinib for metastatic renal cell carcinoma
Promising results in metastatic bladder cancer using immunotherapy
Negative trial results of custirsen for metastatic prostate cancer
Cabozantinib improves PFS in metastatic renal cell carcinoma
Firstline pembrolizumab for metastatic urothelial cancer
miRNA screening for germ cell tumours